Sign in

CIK 0001798749 · <br>Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831377888
Phone
(781) 312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
  1. 10-K Report Annual Report
  2. 425 Deal Prospectus/Communication re Business Combination
  3. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  4. EFFECT Other Notice of Effectiveness
  5. ARS Other Annual Report to Security Holders
  6. 424B3 Offering Prospectus
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. S-4/A Deal Registration Statement - Business Combination
  11. UPLOAD Other SEC-generated Letter
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. S-4/A Deal Registration Statement - Business Combination
  14. UPLOAD Other SEC-generated Letter
  15. 425 Deal Prospectus/Communication re Business Combination
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. S-4/A Deal Registration Statement - Business Combination
  18. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  19. UPLOAD Other SEC-generated Letter
  20. 425 Deal Prospectus/Communication re Business Combination

Page 8 of 26 · 509 filings